Table 2 How-To Guide co-production milestones
How-To Guide for PE | |||
|---|---|---|---|
Co-production milestones | Early discovery and preclinical phases (WG1) | Development of a COA strategy (WG2A) | Clinical trial protocol design (WG2B) |
Version 1: Drafting of initial scope and structure by WG | March–August 2019 | June–August 2019 | June–August 2019 |
Version 1.2: Refinement following internal WG review | Shared for feedback at PE Open Forum September 2019 | Shared for feedback at PE Open Forum, September 2019, and during a standalone working session held in parallel to the International Society for Pharmacoeconomics and Outcomes Research Europe, November 2019 | Shared for feedback at PE Open Forum, September 2019 |
Version 2.0: Refinement following review and feedback | January–June 2020 Shared for feedback at PE Open Forum, June 2020 | January–August 2020 Shared for feedback at PE Open Forum, September 2020 | October 2019–ongoing |
Version 3: Refinement following internal WG and contributor network review | July–November 2020 | October–December 2020 | |
Version 4: Public consultation | December 2020–January 2021 Presented at Patients as Partners, January 2021 | January 2021–ongoing | Planned ~April/July 2021 |